Testing effectiveness (Phase 2)Ended earlyNCT00413959What this trial is testingVELCADE,Rituximab,Cyclophosphamide and DecadronWho this might be right forLymphoma, Non-HodgkinLymphoma, B-Cell Oncology Specialists, S.C. 12
Testing effectiveness (Phase 2)Study completedNCT01281917What this trial is testingStudy of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forNon-Hodgkins Lymphoma University of Wisconsin, Madison 40
Testing effectiveness (Phase 2)Study completedNCT03255018What this trial is testingPembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell LymphomasWho this might be right forNon-Hodgkin LymphomaLymphomaDiffuse Large B-Cell Lymphoma+2 more National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Looking for participantsNCT04068597What this trial is testingStudy to Evaluate CCS1477 (Inobrodib) in Haematological MalignanciesWho this might be right forHaematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more CellCentric Ltd. 250
Testing effectiveness (Phase 2)Ended earlyNCT01343368What this trial is testingPreservation of Ovarian Function After Hematopoietic Cell TransplantWho this might be right forMultiple MyelomaNon-Hodgkin LymphomaHodgkin Disease+2 more Masonic Cancer Center, University of Minnesota 19
Early research (Phase 1)Study completedNCT00390117What this trial is testingAT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphomaUnspecified Adult Solid Tumor, Protocol Specific NCIC Clinical Trials Group 34
Large-scale testing (Phase 3)Ended earlyNCT02703272What this trial is testingA Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin LymphomaWho this might be right forLymphoma, Non-Hodgkin Janssen Research & Development, LLC 72
Testing effectiveness (Phase 2)Ended earlyNCT00265928What this trial is testingBortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma University of Virginia 46
Not applicableStudy completedNCT00281801What this trial is testingCaregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow TransplantationWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Case Comprehensive Cancer Center 168
Testing effectiveness (Phase 2)Ended earlyNCT00074165What this trial is testingTreating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment RegimenWho this might be right forBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more OHSU Knight Cancer Institute 17
Testing effectiveness (Phase 2)Looking for participantsNCT06835530What this trial is testingA Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)Who this might be right forDiffuse Large B Cell Non-Hodgkin Lymphoma Fondazione Italiana Linfomi - ETS 47
Early research (Phase 1)Study completedNCT01231919What this trial is testingMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)Looking for participantsNCT07022964What this trial is testingCD5 CAR T-Cell Therapy for r/r T-cell LymphomasWho this might be right forT-Cell Non-Hodgkin LymphomaT-cell Lymphoma (PTCL and CTCL) Beijing GoBroad Hospital 36
Testing effectiveness (Phase 2)UnknownNCT00002481What this trial is testingCombination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma St. Luke's Medical Center
Early research (Phase 1)Active Not RecruitingNCT03913949What this trial is testingEvaluate the Safety,PK and PD of APG-2575 in Patients With Hematologic MalignanciesWho this might be right forChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma Ascentage Pharma Group Inc. 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT03598998What this trial is testingPembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell LymphomasWho this might be right forAnaplastic Large Cell LymphomaNodal Peripheral T-Cell Lymphoma With TFH PhenotypeRecurrent Anaplastic Large Cell Lymphoma+17 more City of Hope Medical Center 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT05346809What this trial is testingIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaWho this might be right forLymphomaMultiple MyelomaNon-Hodgkin Lymphoma+1 more Divaya Bhutani 8
Early research (Phase 1)Temporarily pausedNCT00077493What this trial is testingBL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma MedImmune LLC 95
Not applicableStudy completedNCT00900484What this trial is testingSWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 458
Early research (Phase 1)Active Not RecruitingNCT04606433What this trial is testingPhase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic LeukemiaWho this might be right forNon Hodgkin LymphomaAcute Lymphoblastic Leukemia Sichuan Baili Pharmaceutical Co., Ltd. 47